Business Standard

Zydus Lifesciences' Rs 600 crore buyback offer to open on Feb 29

The company proposed to buy back up to 59,70,149 shares at Rs 1,005 apiece for an aggregate consideration not exceeding Rs 600 crore, it stated

Cadila Healthcare changes name to Zydus Lifesciences Limited

Press Trust of India New Delhi

Listen to This Article

Zydus Lifesciences on Tuesday said its offer to buy back 59.7 lakh shares at Rs 1,005 apiece, aggregating to Rs 600 crore, will open on February 29.

The share repurchase programme will close on March 6, 2024, the drug firm said in a regulatory filing.

The company proposed to buy back up to 59,70,149 shares at Rs 1,005 apiece for an aggregate consideration not exceeding Rs 600 crore, it stated.

Shares of the company were trading 0.38 per cent up at Rs 946.15 apiece on the BSE.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 27 2024 | 2:06 PM IST

Explore News